Author

Madison C. Jilek

University of Iowa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam J. DupuyiD· 1 shared Adeline A. Hawkins· 1 shared Afshin VarzavandiD· 1 shared Christopher S. StippiD· 1 shared Elizabeth C. HannaniD· 1 shared Faith A. Bibeau· 1 shared Jesse D. RiordaniD· 1 shared Jonathan A. PachteriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam J. DupuyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibition

Jesse D. Riordan, Teagan A. Nathanson, Afshin Varzavand, Adeline A. Hawkins, Rebekah M. Peplinski, Elizabeth C. Hannan, Faith A. Bibeau, Nathaniel J. Freesmeier, Madison C. Jilek, Silvia Coma, Jonathan A. Pachter, Adam J. Dupuy, Christopher S. Stipp

This study identifies FAK signaling as a critical target for overcoming Rac1-driven MAPK resistance in melanoma and shows that combining RAF/MEK and FAK inhibitors is effective.

Oncogene · Oct 18, 2025Peer-reviewedCancer Biology